SS-262

N/A

Report date: 2024/11/20 14:15:30
NME

Base Information

Drug NameSS-262
Drug Alias NameSS-262
ClassificationSmall molecules
Mechanisms of ActionMelatonin receptor modulators
TargetsMelatonin receptor
Therapy Area/IndicationsSleep Initiation and Maintenance Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSinsin Pharmaceutical
China Registration ClassN/A

Develop Information

Active CompaniesSinsin Pharmaceutical
Inactive CompaniesN/A
Active IndicationsSleep Initiation and Maintenance Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A